The effects of nitric oxide donor molsidomine on skeletal muscle damage in a rat hind limb model of ischemia-reperfusion

European Surgical Research

Volumn 42, Issue 2, 2009, Pages 71-77

  Ozturk K ^a,d   Ozyurt, H ^c   Somay, A ^a   Karaca, C ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c GAZIOSMANPASA UNIVERSITY   (Turkey)

^d Vakif Gureba Research and Education Hospital   (Turkey)

Author keywords

Ischemia reperfusion injury; Limb ischemia; Molsidomine; Nitric oxide; Skeletal muscle

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MOLSIDOMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; RUBBER; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; GASTROCNEMIUS MUSCLE; HINDLIMB; HISTOPATHOLOGY; MALE; MUSCLE CELL; MUSCLE INJURY; MUSCLE ISCHEMIA; MUSCLE NECROSIS; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; REPERFUSION INJURY; SCORING SYSTEM; SHAM PROCEDURE; SKELETAL MUSCLE; THIGH; TISSUE LEVEL;

ANIMALS; LOWER EXTREMITY; MALE; MOLSIDOMINE; MUSCLE, SKELETAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE DONORS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 55749111698     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000171070     Document Type: Article

References (35)

1. Atahan E, Ergun Y, Belge Kurutas E, Cetinus E, Guney Ergun U: Ischemia-reperfusion injury in rat skeletal muscle is attenuated by zinc aspartate. J Surg Res 2007;137:109-116.
2. Wakai A, Wang JH, Winter DC, Street JT, O'Sullivan RG, Redmond HP: Tourniquet-induced systemic inflammatory response in extremity surgery. J Trauma 2001;51:922-926.
3. Dillon JP, Laing AJ, Chandler JR, Wang JH, McGuinness A, Redmond HP: Pravastatin attenuates tourniquet-induced skeletal muscle ischemia reperfusion injury. Acta Orthop 2006;77:27-32.
4. Pierce GN, Czubryt MP: The contribution of ionic imbalance to ischemia/reperfusion-induced injury. J Mol Cell Cardiol 1995;27:53-63.
5. Nayler WG, Panagiotopoulos S, Elz JS, Daly MJ: Calcium-mediated damage during post-ischaemic reperfusion. J Mol Cell Cardiol 1988;20(suppl 2):41-54.
6. Kloner RA, Ganote CE, Jennings RB: The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-1508.
7. Lindsay T, Romaschin A, Walker PM: Free radical mediated damage in skeletal muscle. Microcirc Endothelium Lymphatics 1989;5:157-170.
8. Nanobashvili J, Neumayer C, Fuegl A, Punz A, Blumer R, Mittlbock M, et al: Combined L-arginine and antioxidative vitamin treatment mollifies ischemia-reperfusion injury of skeletal muscle. J Vasc Surg 2004;39:868-877.
9. Rosenkranz B, Winkelmann BR, Parnham MJ: Clinical pharmacokinetics of molsidomine. Clin Pharmacokinet 1996;30:372-384.
10. Rodeberg DA, Chaet MS, Bass RC, et al: Nitric oxide: an overview. Am J Surg 1995;170:292-303.
11. Walder CE, Thiemermann C, Vane JR: The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol 1991;102:967-973.
12. National Research Council: Guides for the Care and Use of Laboratory Animals. Washington, National Academy Press, 1996.
13. Messina A, Knight KR, Dowsing BJ, Zhang B, Phan LH, Hurley JV, et al: Timing of administration of dexamethasone or the nitric oxide synthase inhibitor, nitro-L-arginine methyl ester, is critical for the effective treatment of ischaemia-reperfusion injury to rat skeletal muscle. Clin Sci 1997;93:167-174.
14. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
15. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351.
16. Sun Y, Oberley LW, Ying L: A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
17. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
18. Aebi H: Catalase; in Bergmeyer U (ed): Methods of Enzymatic Analysis. New York, Academic Press, 1974, pp 673-677.
19. Cortas NK, Wakid NW: Determination of inorganic nitrate in serum and urine by a kinetic cadmium reduction method. Clin Chem 1990;36:1440-1443.
20. Ullrich R, Roeder G, Lorber C, Quezado ZM, Kneifel W, Gasser H, et al: Continuous venovenous hemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs. Anesthesiology 2001;95:428-436.
21. Kearns SR, Monoley D, Murray P, Kelly C, Daly AF: Oral vitamin C attenuates acute ischaemia-reperfusion injury in skeletal muscle. J Bone Joint Surg Br 2001;83:1202-1206.
22. Büttemeyer R, Philipp AW, Mall JW, Ge B, Scheller FW, Lisdat F: In vivo measurement of oxygen-derived free radicals during reperfusion injury. Microsurgery 2002;22:108-113.
23. Welbourn CR, Goldman G, Paterson IS: Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg 1991;78:651-655.
24. Weinbroum AA, Hochhauser E, Rudick V, Kluger Y, Karchevsky E, Graf E, et al: Multiple organ dysfunction after remote circulatory arrest: common pathway of radical oxygen species? J Trauma 1999;474:691-698.
25. Halliwell B, Gutteridge JM, Cross CE: Free radicals, antioxidant and human disease: where are we now? J Lab Clin Med 1992;119:598-620.
26. Garcia JJ, Reiter RJ, Guerrero JM, Escames G, Yu BP, Oh CS, Munoz-Hoyos A: Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997;408:297-300.
27. Trimarchi H, Mongitore MR, Baglione P, Forrester M, Freixas EA, Schropp M, et al: N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients - a pilot study. Clin Nephrol 2003;59:441-446.
28. Freudenthaler SM, Schreeb KH, Wiese A, Pilz J, Gleiter CH: Influence of controlled hypoxia and radical scavenging agents on erythropoietin and malondialdehyde concentration in humans. Acta Physiol Scand 2002;174:231-235.
29. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2006.
30. Gros SS, Wolin MS: Nitric oxide: pathophysiologic mechanisms. Annu Rev Physiol 1995;57:737-769.
31. Oztürk H, Aldemir M, Dokucu AI, Yagmur Y, Kilinc N, Sahin AH: The nitric oxide donor molsidomine prevents ischemia/reperfusion injury of the adult rat small intestine. Pediatr Surg Int 2003;19:305-308.
32. Adams ML, Meyer ER, Sewing BN, et al: Effects of nitric oxide-related agents on rat testicular function. J Pharmacol Exp Ther 1994;269:230-237.
33. Myers SI, Hernandez R, Castaneda A: Possible role for oxygen free radicals in the regulation of renal nitric oxide synthesis and blood flow. Am J Surg 1995;169:604-608.
34. Gross SS, Wolin MS: Nitric oxide: pathophysiologic mechanisms. Annu Rev Physiol 1995;57:737-769.
35. Kukovetz WR, Holzmann S: Cyclic GMP as the mediator of molsidomine-induced vasodilatation. Eur J Pharmacol 1986;122:130-109.